ArticleFoods (Basel, Switzerland)2025
Natural Deep Eutectic Solvents Enhance the Bioavailability and Antioxidant Activity of Oleanolic Acid in Self-Constructed Pickering High Internal Phase Emulsions.
Article in Foods (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Evaluating the suitability of six hydrophobic natural eutectic solvents as the internal phase in a cosmetic cream formulation.International journal of cosmetic science · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Oleanolic acid (OA)-stabilized water-in-oil Pickering high internal phase emulsions (HIPEs), using natural deep eutectic solvents (NADESs) as the internal phase (HIPE-NADES), were developed to enhance OA bioavailability. Three kinds of NADESs (proline: sorbitol (1:1), proline: glucose (1:1), and proline: glucose (5:3)) were selected, and HIPEs with pure water as the internal phase were used as the control group. In vitro digestion and Caco-2 models showed that HIPE-NADES significantly improved OA bioaccessibility via enhanced stability and solubility. Crucially, OA bioavailability reached 16.20-19.10%, markedly surpassing controls (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.